ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs MXN
17.74275
0.07%
Brent Oil
83.585
-0.90%
Bitcoin
63,483.98
-2.10%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Nkarta Inc (NKTX)

  7. Nkarta Inc (NKTX) Noticias

NKTX

Nkarta (NKTX)

Nkarta Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:NKTX
FechaHoraFuenteTítuloSímboloCompañía
12/08/202116:05Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:NKTXNkarta Inc
12/08/202115:38Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NKTXNkarta Inc
12/08/202115:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NKTXNkarta Inc
12/08/202115:02GlobeNewswire Inc.Nkarta Reports Second Quarter 2021 Financial Results and Business ProgressNASDAQ:NKTXNkarta Inc
04/08/202115:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NKTXNkarta Inc
14/07/202106:00GlobeNewswire Inc.Nkarta Establishes New Combined NK Cell Therapy Manufacturing Facility / Company HeadquartersNASDAQ:NKTXNkarta Inc
12/07/202107:31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NKTXNkarta Inc
16/06/202106:00GlobeNewswire Inc.Nkarta to Present at Upcoming Investor ConferenceNASDAQ:NKTXNkarta Inc
14/06/202106:01GlobeNewswire Inc.Nkarta Therapeutics CEO, Paul Hastings, Named BIO Chair for 2021-2022 TermNASDAQ:NKTXNkarta Inc
25/05/202106:30GlobeNewswire Inc.Nkarta Announces June 2021 Investor Conference ScheduleNASDAQ:NKTXNkarta Inc
13/05/202115:02GlobeNewswire Inc.Nkarta Reports First Quarter 2021 Financial Results and Business ProgressNASDAQ:NKTXNkarta Inc
06/05/202115:01GlobeNewswire Inc.CRISPR Therapeutics and Nkarta Announce Global Collaboration to Develop Gene-Edited Cell Therapies for CancerNASDAQ:NKTXNkarta Inc
28/04/202107:02GlobeNewswire Inc.Nkarta Receives NKX019 IND Clearance from U.S. Food and Drug Administration for Treatment of Relapsed/Refractory B Cell Malig...NASDAQ:NKTXNkarta Inc
25/03/202118:26Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NKTXNkarta Inc
25/03/202115:03GlobeNewswire Inc.Nkarta Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Business ProgressNASDAQ:NKTXNkarta Inc
17/02/202115:03GlobeNewswire Inc.Nkarta Announces February and March 2021 Investor Conference ScheduleNASDAQ:NKTXNkarta Inc
02/02/202114:17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NKTXNkarta Inc
15/01/202113:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NKTXNkarta Inc
12/11/202015:03GlobeNewswire Inc.Nkarta Reports Third Quarter 2020 Financial ResultsNASDAQ:NKTXNkarta Inc
12/11/202015:02GlobeNewswire Inc.Nkarta Announces Treatment of First Patient in First-in-Human Clinical Trial of Engineered NKG2D-Based NK Cell Cancer Immunot...NASDAQ:NKTXNkarta Inc
09/11/202007:02GlobeNewswire Inc.Nkarta Announces Presentation of Preclinical Data on NKX019, Engineered NK Cell Therapy Candidate Targeting CD19, at the Annu...NASDAQ:NKTXNkarta Inc
05/11/202015:02GlobeNewswire Inc.Nkarta Announces November & December 2020 Investor Conference ScheduleNASDAQ:NKTXNkarta Inc
28/10/202017:28Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NKTXNkarta Inc
05/10/202015:02GlobeNewswire Inc.Nkarta Announces Leadership ChangesNASDAQ:NKTXNkarta Inc
29/09/202007:02GlobeNewswire Inc.Nkarta Announces October 2020 Investor Conference ScheduleNASDAQ:NKTXNkarta Inc
08/09/202015:02GlobeNewswire Inc.Nkarta Announces September 2020 Virtual Investor Conference ScheduleNASDAQ:NKTXNkarta Inc
20/08/202015:02GlobeNewswire Inc.Nkarta Reports Second Quarter 2020 Financial ResultsNASDAQ:NKTXNkarta Inc
24/07/202015:34Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:NKTXNkarta Inc
14/07/202015:15GlobeNewswire Inc.Nkarta Announces Closing of Upsized Initial Public Offering and Exercise in Full of Underwriters' Option to Purchase Addition...NASDAQ:NKTXNkarta Inc
09/07/202023:44GlobeNewswire Inc.Nkarta Announces Pricing of Initial Public OfferingNASDAQ:NKTXNkarta Inc
 Showing the most relevant articles for your search:NASDAQ:NKTX

Su Consulta Reciente

USOTC
BNPQY
BNP Paribas (QX)
AMEX
SPY
SPDR S&P 500
COIN
ETHUSD
Ethereum
AMEX
XLE
Energy Select Sector SPDR
USOTC
RHHBY
Roche (QX)
USOTC
BASFY
BASF (QX)
COIN
SOLUSD
Solana
NYSE
JPM
JP Morgan Chase
USI
USTECH100
US Tech 100
FX
EURUSD
Euro vs US Dollar
NYSE
VZ
Verizon Communications
COIN
BTCUSD
Bitcoin
NASDAQ
AAPL
Apple
FX
EURMXN
Euro vs MXN
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados